Cetuximab Monotherapy Maintenance Treatment in mCRC
Ontology highlight
ABSTRACT: Investigating the efficacy of Cetuximab Monotherapy versus Continuation after induction treatment with chemotherapy + Cetuximab in inoperable or irresectable and non-progressive metastatic colorectal cancer after first line induction treatment for 24 weeks with mFOLFOX6/FOLFIRI and Cetuximab treatment. Reinduction treatment will be done in case of progression.
DISEASE(S): Colorectal Cancer,Colorectal Neoplasms
PROVIDER: 2230951 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA